We are live on
!
Find out more
CK
Cohen Klingenstein Portfolio holdings
AUM
$3.49B
1-Year Est. Return
26.65%
This Fund
S&P 500
This Quarter
Est. Return
+4.61%
1 Year Est. Return
+26.65%
3 Year Est. Return
+87.7%
5 Year Est. Return
+104.29%
10 Year Est. Return
+422.19%
AUM
$2.76B
AUM Growth
+$68.9M
(+2.6%)
Cap. Flow
-$20.4M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
53.37%
Holding
224
New
2
Increased
5
Reduced
44
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$1.29M |
| 2 |
Vanguard Morningstar Small-Cap Growth ETF
VBK
|
+$634K |
| 3 |
Solventum
SOLV
|
+$549K |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$26.2K |
| 5 |
Vanguard Morningstar Mid-Cap Growth ETF
VOT
|
+$14.9K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.08M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$3.69M |
| 3 |
Eli Lilly
LLY
|
+$1.44M |
| 4 |
GE Aerospace
GE
|
+$1.32M |
| 5 |
SEE
Sealed Air
SEE
|
+$1.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.01% |
| 2 | Healthcare | 9.84% |
| 3 | Financials | 9.18% |
| 4 | Communication Services | 9% |
| 5 | Consumer Discretionary | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Bristol-Myers Squibb
BMY
$132B
| $2.88M | 0.1% |
69,400
| – | – |
|
102
Otis Worldwide
OTIS
$27.3B
| $2.82M | 0.1% |
29,307
| – | – |
|
103
Vertex Pharmaceuticals
VRTX
$122B
| $2.81M | 0.1% |
6,000
| – | – |
|
104
Caterpillar
CAT
$373B
| $2.66M | 0.1% |
8,000
| – | – |
|
105
TJX Companies
TJX
$176B
| $2.6M | 0.09% |
23,600
| – | – |
|
106
WisdomTree India Earnings Fund ETF
EPI
$2.06B
| $2.59M | 0.09% |
53,600
| – | – |
|
107
Automatic Data Processing
ADP
$105B
| $2.56M | 0.09% |
10,705
| – | – |
|
108
Progressive
PGR
$124B
| $2.49M | 0.09% |
12,000
| – | – |
|
109
Graham Holdings Company
GHC
$5.28B
| $2.48M | 0.09% |
3,540
| – | – |
|
110
Gen Digital
GEN
$16.3B
| $2.46M | 0.09% |
98,600
| – | – |
|
111
Nike
NKE
$62.7B
| $2.45M | 0.09% |
32,500
| – | – |
|
112
Gilead Sciences
GILD
$163B
| $2.45M | 0.09% |
35,700
| – | – |
|
113
Corning
GLW
$116B
| $2.42M | 0.09% |
62,380
-5,370
| -8% | -$188K |
|
114
S&P Global
SPGI
$122B
| $2.41M | 0.09% |
5,400
| – | – |
|
115
Boston Scientific
BSX
$68.4B
| $2.35M | 0.09% |
30,500
| – | – |
|
116
Altria Group
MO
$113B
| $2.34M | 0.09% |
51,448
-31
| -0.1% | -$1.38K |
|
117
Starbucks
SBUX
$121B
| $2.34M | 0.09% |
30,100
| – | – |
|
118
Chubb
CB
$135B
| $2.33M | 0.08% |
9,120
| – | – |
|
119
Boeing
BA
$175B
| $2.31M | 0.08% |
12,700
| – | – |
|
120
Applied Materials
AMAT
$398B
| $2.27M | 0.08% |
9,600
| – | – |
|
121
Deere & Co
DE
$162B
| $2.24M | 0.08% |
6,000
| – | – |
|
122
Cigna
CI
$76.1B
| $2.18M | 0.08% |
6,600
| – | – |
|
123
Stryker
SYK
$133B
| $2.18M | 0.08% |
6,400
| – | – |
|
124
Morgan Stanley
MS
$330B
| $2.12M | 0.08% |
21,800
| – | – |
|
|
MRSH
125
Marsh
MRSH
$91.4B
| $2.11M | 0.08% |
10,000
| – | – |
|
Similar funds
DILIC
TCM
KCM
ACM
MSC
BCP
PMG
ACA
Cohen Klingenstein's Q2 2024 Portfolio in Review
As of Q2 2024, Cohen Klingenstein held 224 positions worth $2.76B, up 2.6% from $2.69B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Trading was light in Q2 2024: portfolio turnover was 1.8%. Cohen Klingenstein opened 2 new positions and exited 2, leaving the 224-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- Cohen Klingenstein's largest Q2 2024 buy was GE Vernova: 8,143 shares worth $1.4M.
- Cohen Klingenstein added most to Vanguard Morningstar Small-Cap Growth ETF in Q2 2024, an estimated $634K increase.
- Cohen Klingenstein's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.08M.
- Cohen Klingenstein fully exited State Street in Q2 2024, selling an estimated $205K.
- Cohen Klingenstein's ten largest holdings make up 53% of its $2.76B portfolio in Q2 2024.
- Cohen Klingenstein opened 2 new positions and closed 2 in Q2 2024.
- Cohen Klingenstein's portfolio value rose 2.6% quarter-over-quarter to $2.76B.
Based on Cohen Klingenstein's 13F filing for Q2 2024, filed 15 Jul 2024.